Loading...
Loading...
India's hydrochlorothiazide imports from UNITED STATES total $1.6M across 300 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $1.2M in import value; the top 5 suppliers together control 91.2% of this origin. Leading Indian buyers include IPCA LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for hydrochlorothiazide — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Hydrochlorothiazide supplier from UNITED STATES to India, with import value of $1.2M across 24 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, NEWLIFE MEDICALS (USA). INC, AMSTERDAM PHARMA (APTEKA RX INC.), REGIONAL PHARMACY, Espee Biopharma & Finechem LLC — collectively account for 91.2% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $1.2M | 24 | 74.9% |
| 2 | NEWLIFE MEDICALS (USA). INC | $194.3K | 6 | 12.5% |
| 3 | AMSTERDAM PHARMA (APTEKA RX INC.) | $26.5K | 9 | 1.7% |
| 4 | REGIONAL PHARMACY | $19.2K | 9 | 1.2% |
| 5 | Espee Biopharma & Finechem LLC | $12.6K | 6 | 0.8% |
| 6 | AGRACE PHARMA | $11.4K | 7 | 0.7% |
| 7 | M/S RAFF & HALL PHARMACY | $11.1K | 15 | 0.7% |
| 8 | GOOD HEALTH PHARMA SUPPLIES | $11.0K | 2 | 0.7% |
| 9 | RAFF & HALL PHARMACY | $10.1K | 6 | 0.6% |
| 10 | AMSTERDAM PHARMA (APTEKA RX INC) | $9.8K | 3 | 0.6% |
| 11 | ADIRAMEDICA LLC | $9.1K | 2 | 0.6% |
| 12 | ESPEE BIOPHARMA & FINECHEM LLC. | $7.8K | 2 | 0.5% |
| 13 | RX MEDISOURCE LLC | $6.9K | 10 | 0.4% |
| 14 | Raff & Hall Pharmacy | $6.7K | 2 | 0.4% |
| 15 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $4.4K | 4 | 0.3% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $1.3M | 9 | 82.2% |
| 2 | AJANTA PHARMA LIMITED | $48.1K | 22 | 3.1% |
| 3 | UNICHEM LABORATORIES LIMITED | $42.1K | 8 | 2.7% |
| 4 | LAURUS LABS LIMITED | $36.6K | 17 | 2.4% |
| 5 | ZYDUS LIFESCIENCES LIMITED | $21.8K | 14 | 1.4% |
| 6 | HETERO LABS LIMITED | $16.4K | 18 | 1.1% |
| 7 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $13.9K | 17 | 0.9% |
| 8 | MICRO LABS LIMITED | $11.8K | 4 | 0.8% |
| 9 | MSN LABORATORIES PRIVATE LIMITED | $11.2K | 8 | 0.7% |
| 10 | AUROBINDO PHARMA LTD | $10.6K | 17 | 0.7% |
| 11 | HETERO LABS LIMITED | $9.4K | 1 | 0.6% |
| 12 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | $9.1K | 2 | 0.6% |
| 13 | CLIANTHA RESEARCH LIMITED | $7.6K | 5 | 0.5% |
| 14 | MYLAN LABORATORIES LIMITED | $5.5K | 2 | 0.4% |
| 15 | RUBICON RESEARCH PRIVATE LIMITED | $4.5K | 4 | 0.3% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Hydrochlorothiazide suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, NEWLIFE MEDICALS (USA). INC, AMSTERDAM PHARMA (APTEKA RX INC.). The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $1.2M USD across 24 shipments. India imported Hydrochlorothiazide worth $1.6M USD from UNITED STATES in total across 300 shipments.
India imported Hydrochlorothiazide worth $1.6M USD from UNITED STATES across 300 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Hydrochlorothiazide sourced from UNITED STATES include IPCA LABORATORIES LIMITED, AJANTA PHARMA LIMITED, UNICHEM LABORATORIES LIMITED. The largest buyer is IPCA LABORATORIES LIMITED with $1.3M in imports across 9 shipments.
The total value of Hydrochlorothiazide imports from UNITED STATES to India is $1.6M USD, across 300 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
300 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists